|
May 14, 2021: Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: Effects Of Interleukin-6 Inhibition With Ziltivekimab On Biomarkers O |
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: Effects Of Interleukin-6 Inhibition With Ziltivekimab On Biomarkers Of Inflammation Among Patients At High Risk For Atherosclerotic Events
TBD
[ Download video ] |
|
No comments have been submitted
|